.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for Patent: 7,291,132

« Back to Dashboard
Patent 7,291,132 protects HUMALOG MIX 75/25 KWIKPEN, HUMULIN 70/30, HUMULIN 70/30 PEN, HUMALOG MIX 50/50 KWIKPEN, HUMALOG KWIKPEN, HUMULIN R, and HUMULIN N, and is included in seven NDAs.

This patent has twelve patent family members in nine countries.

Summary for Patent: 7,291,132

Title:Medication dispensing apparatus with triple screw threads for mechanical advantage
Abstract: A medication dispensing apparatus that provides a mechanical advantage. During dose preparing, a nut rotating element (410) and a screw element (368) are in a first axial arrangement such that a screwing motion of the nut rotating element and screw element relative to the apparatus housing that moves the elements a first axial distance from a home position screws a nut (364) along a drive member threaded shaft (362) a second axial distance different than the first axial distance. During dose dispensing, the nut rotating element and the screw element are in a second axial arrangement, whereby a screwing motion of the screw element relative to the housing back toward the home position advances a plunger (366) in the distal direction to axially advance the nut and thereby the drive member and a fluid container piston to dispense medicine.
Inventor(s): DeRuntz; Otto Daniel (Dunstable, MA), Focht; Kenneth Allen (Needham, MA), Jacobs; Alexander Thomas (Somerville, MA), Johansen; Elizabeth Whitney (Allston, MA), Judson; Jared Alden (Topsfield, MA)
Assignee: Eli Lilly and Company (Indianapolis, IN)
Application Number:10/567,196
Patent Claim Types:
see list of patent claims
Device; Use;
Patent Metrics:
Source: PatentQuant.com
Field: Medical technology
Back Citations: 43rd percentile
Forward Citations: 7th percentile

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Lilly
HUMALOG MIX 75/25 KWIKPEN
insulin lispro protamine recombinant; insulin lispro recombinant
INJECTABLE;INJECTION021017-002Sep 6, 2007RXYes7,291,132► subscribeY
Lilly
HUMULIN 70/30
insulin recombinant human; insulin susp isophane recombinant human
INJECTABLE;INJECTION019717-001Apr 25, 1989OTCYes7,291,132► subscribeY
Lilly
HUMULIN 70/30 PEN
insulin recombinant human; insulin susp isophane recombinant human
INJECTABLE;INJECTION019717-002Aug 6, 1998OTCYes7,291,132► subscribeY
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Foreign Priority and PCT Information for Patent: 7,291,132

PCT Information
PCT FiledAugust 09, 2004PCT Application Number:PCT/US2004/022312
PCT Publication Date:March 03, 2005PCT Publication Number: WO2005/018721

Non-Orange Book Patents for Patent: 7,291,132

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
7,427,275Medication dispensing apparatus with triple screw threads for mechanical advantage► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Patent: 7,291,132

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Norway20061150► subscribe
South Korea101121317► subscribe
South Korea20060061822► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc